Three-year Cerebrolysin cohort: exploratory analysis of cognitive decline
Observational study · 2013
- What was studied
- 53 treated participants with amnestic mild cognitive impairment, 40 women and 13 men.
- Main finding
- Three of 53 treated participants developed Alzheimer’s dementia during three years. An exploratory cluster analysis identified a group of 19 with poorer cognitive-test profiles.
Conversion to Alzheimer’s dementia · 3/53 · Three years
Reported findings and study design
Exploratory cluster and discriminant analyses of repeated neuropsychological scores in the treated series.
Population or model 53 treated participants with amnestic mild cognitive impairment, 40 women and 13 men.
Dose, route and schedule
Twice-yearly courses for three years. Each four-week course included 20 intravenous infusions of 30 mL Cerebrolysin in 100 mL saline.
Protocol source ↗ · Original publisher text, cohort methods and analyses.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Conversion to Alzheimer’s dementia | 3/53 | Three years |
| Exploratory poorer-profile cluster | 19/53 | Defined in the analysis, without external validation. |
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- All participants received Cerebrolysin. The analysis has no contemporaneous untreated group and cannot estimate a treatment effect on dementia conversion.
- A related 110-person comparison was published in 2010. Participant overlap is unresolved.
Source details
Original publisher text, cohort methods and analyses.
Sources checked
Citation
S. I. Gavrilova and colleagues. Three-year Cerebrolysin cohort: exploratory analysis of cognitive decline Korsakov Journal of Neurology and Psychiatry. 2013;113(3):45–53. PMID 23612410.